Article By:
Wall Street Daily
Friday, December 16, 2016 9:37 AM EST
This particular bureaucracy neither gives nor takes. Data do. If a drug works, the company that develops it will do well. If a drug doesn’t work, the company that develops it had better have a diversified pipeline.